MPM Oncology Impact Management »

Scholar Rock Hldg Corp shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Scholar Rock Hldg Corp (SRRK) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Scholar Rock Hldg Corp

Tip: Access up to 7 years of quarterly data

All positions including Scholar Rock Hldg Corp held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scholar Rock Hldg Corp by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.6M 1.0M 8.33

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Scholar Rock Hldg Corp

Siren
T. Rowe Price Associates
Samsara BioCapital
BlackRock
BlackRock
Redmile Group
Vanguard Group
State Street Corporation
Eventide Asset Management
Bellevue Group
Geode Capital Management
Goldman Sachs Group
MPM Oncology Impact Management
ClearBridge Advisors
Citadel Advisors

View all funds holding Scholar Rock Hldg Corp